Vycor Medical (VYCO) Shareholder's Equity Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vycor Medical | - | - | 375,153.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.31% |
| Dec 31, 2025 | -15.58% |
| Sep 30, 2025 | -16.10% |
| Jun 30, 2025 | -18.24% |
| Mar 31, 2025 | -20.09% |
| Dec 31, 2024 | -22.20% |
| Sep 30, 2024 | -23.79% |
| Jun 30, 2024 | -27.95% |
| Mar 31, 2024 | -29.19% |
| Dec 31, 2023 | -34.03% |
| Sep 30, 2023 | -50.41% |
| Jun 30, 2023 | -65.95% |
| Mar 31, 2023 | -60.56% |
| Dec 31, 2022 | -107.11% |
| Sep 30, 2022 | -54.65% |
| Jun 30, 2022 | -38.21% |
| Mar 31, 2022 | -40.34% |
| Dec 31, 2021 | 147.35% |
| Sep 30, 2021 | -50.27% |
| Jun 30, 2021 | -39.65% |
| Mar 31, 2021 | -35.65% |
| Dec 31, 2020 | -29.04% |
| Mar 31, 2020 | -21.62% |
| Dec 31, 2019 | -18.89% |
| Sep 30, 2019 | -18.83% |
| Jun 30, 2019 | -21.90% |
| Mar 31, 2019 | -31.64% |
| Sep 30, 2018 | 31.69% |
| Jun 30, 2018 | 36.96% |
| Mar 31, 2018 | 32.53% |
| Dec 31, 2017 | 15.50% |
| Sep 30, 2017 | 18.65% |
| Jun 30, 2017 | 31.39% |
| Mar 31, 2017 | 14.39% |
| Dec 31, 2016 | -15.21% |
| Sep 30, 2016 | -25.52% |
| Jun 30, 2016 | -19.48% |
| Dec 31, 2015 | 69.90% |